Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
WORTH IT OR FLOP? depends on what you expect it to do I keep seeing that exact framingworth it or flopand I think its the right question, but only if expectations are realistic
Notably, since the studys, prices have started to fall
A double-blinded placebo-controlled phase 2 clinical study in obese patients weekly injections of mazdutide (9 mg) could cause 15.4% decreases in body weight over placebo after 24 weeks
What to eat: Shift to smaller, more frequent meals
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) A substudy of the phase 2 obesity trial specifically examined GLP3 s effects on liver fat in participants with metabolic dysfunction-associated steatotic liver disease[12]: Mean relative liver fat reduction of 82.4% with 12 mg dose at 24 weeks 86% of participants on 12 mg achieved normal liver fat levels (below 5%) at 24 weeks Liver fat reductions significantly correlated with improvements in insulin sensitivity, abdominal fat, and metabolic parameters Dose-dependent improvements observed across all dose groups compared to placebo These results suggest potential therapeutic applications beyond weight management, addressing hepatic complications of obesity and metabolic syndrome
Brown-edged or faded petals mean oxidation
